IVR-Enhanced Care Transition Support for Complex Patients
Congestive Heart Failure, Chronic Obstructive Pulmonary Disease
About this trial
This is an interventional health services research trial for Congestive Heart Failure focused on measuring care transitions, information technology
Eligibility Criteria
Inclusion Criteria:
- CHF/COPD patients
- English-speaking
- Medicare beneficiaries
Amendment to Inclusion Criteria:
- Recruited non-Medicare eligible beneficiaries
Exclusion Criteria:
- Prognosis of 6 months or less
- Cognitive impairment with no available proxy/caregiver
- No possession of a phone
Amendments to exclusion criteria:
- heart or lung transplant recipients
- dialysis patients
- individuals already in the Cystic Fibrosis program or receiving intensive monitored care
- individuals with a ventricular assist device (LVAD; RVAD; BiVAD)
- individuals utilizing a pre-paid phone service
Sites / Locations
- University Hospital and UAB Highlands
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
No Intervention
No Intervention
CHF patients, IVR-Enhanced Care
COPD patients, IVR-Enhanced Care
CHF patients, Usual Discharge Care
COPD patients, Usual Discharge Care
Patients with congestive heart failure (CHF) who receive the interactive voice response (IVR) intervention.
Patients with chronic obstructive pulmonary disease (COPD) who receive the interactive voice response (IVR) intervention.
Patients with congestive heart failure (CHF) who receive usual discharge care (no intervention).
Patients with chronic obstructive pulmonary disease (COPD) who receive usual discharge care (no intervention).